APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tubular Injection Vial

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tubular Injection Vial Market Analysis and Forecast 2026-2032

5 June 2026217 pages

Choose your research edition.

Industry ResearchTubular Injection Vial Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Tubular Injection Vial Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tubular Injection Vial Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tubular Injection Vial Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Tubular Injection Vial Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Tubular Injection Vial market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tubular Injection Vial is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tubular Injection Vial is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tubular Injection Vial is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tubular Injection Vial is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tubular Injection Vial include SGD, SCHOTT Pharma, Gerresheimer AG, DWK Life Sciences, Stevanato Group, Corning, Nipro Corporation, Daikyo Seiko and West Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tubular Injection Vial, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tubular Injection Vial, also provides the sales of main regions and countries. Of the upcoming market potential for Tubular Injection Vial, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tubular Injection Vial sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tubular Injection Vial market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tubular Injection Vial sales, projected growth trends, production technology, application and end-user industry.

Tubular Injection Vial Segment by Company

SGD

SCHOTT Pharma

Gerresheimer AG

DWK Life Sciences

Stevanato Group

Corning

Nipro Corporation

Daikyo Seiko

West Pharmaceutical

Radpharm Scientific

Pacific Vial Manufacturing

Ningbo Zhengli Pharmaceutical Packaging

Linuo Pharmaceutical Packaging

Chongqing Zhengchuan Pharmaceutical Packaging

Shandong Pharmaceutical Glass

CANGZHOU FOUR STARS GLASS

Anhui Huaxin Pharmaceutical Glass Products

Jiyuan Zhengyu Industrial

Taian Youlyy Industrial

Nantong Xinde Medical Packing Material

Chengdu Jingu Medicinal Packing

Tubular Injection Vial Segment by Type

Low Borosilicate Tubular Injection Vial

Medium Borosilicate Tubular Injection Vial

High Borosilicate Tubular Injection Vial

Soda-lime Tubular Injection Vial

Tubular Injection Vial Segment by Application

Biologicals

Lyophilized Powder Injection

Vaccines

Other

Tubular Injection Vial Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tubular Injection Vial market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tubular Injection Vial and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tubular Injection Vial.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tubular Injection Vial in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tubular Injection Vial manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tubular Injection Vial sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tubular Injection Vial Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Low Borosilicate Tubular Injection Vial Major Manufacturers Table 3. Medium Borosilicate Tubular Injection Vial Major Manufacturers Table 4. High Borosilicate Tubular Injection Vial Major Manufacturers Table 5. Soda-lime Tubular Injection Vial Major Manufacturers Table 6. Global Tubular Injection Vial Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Biologicals Major Manufacturers Table 8. Lyophilized Powder Injection Major Manufacturers Table 9. Vaccines Major Manufacturers Table 10. Other Major Manufacturers Table 11. Tubular Injection Vial Industry Trends Table 12. Tubular Injection Vial Industry Drivers Table 13. Tubular Injection Vial Industry Opportunities and Challenges Table 14. Tubular Injection Vial Industry Restraints Table 15. Global Tubular Injection Vial Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Tubular Injection Vial Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Tubular Injection Vial Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Tubular Injection Vial Revenue Market Share by Region (2021-2026) Table 19. Global Tubular Injection Vial Revenue Market Share by Region (2027-2032) Table 20. Global Tubular Injection Vial Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M units) Table 21. Global Tubular Injection Vial Sales by Region (2021-2026) & (M units) Table 22. Global Tubular Injection Vial Sales by Region (2027-2032) & (M units) Table 23. Global Tubular Injection Vial Sales Market Share by Region (2021-2026) Table 24. Global Tubular Injection Vial Sales Market Share by Region (2027-2032) Table 25. Global Tubular Injection Vial Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Tubular Injection Vial Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Tubular Injection Vial Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Tubular Injection Vial Sales Market Share by Manufacturers (2021-2026) Table 29. Global Tubular Injection Vial Sales Price (USD/unit) of Manufacturers (2021-2026) Table 30. Global Tubular Injection Vial Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Tubular Injection Vial Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Tubular Injection Vial Manufacturers, Product Type & Application Table 33. Global Tubular Injection Vial Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Tubular Injection Vial by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Tubular Injection Vial Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Tubular Injection Vial Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Tubular Injection Vial Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Tubular Injection Vial Revenue Market Share by Type (2021-2026) Table 40. Global Tubular Injection Vial Revenue Market Share by Type (2027-2032) Table 41. Global Tubular Injection Vial Sales by Type 2021 VS 2025 VS 2032 (M units) Table 42. Global Tubular Injection Vial Sales by Type (2021-2026) & (M units) Table 43. Global Tubular Injection Vial Sales by Type (2027-2032) & (M units) Table 44. Global Tubular Injection Vial Sales Market Share by Type (2021-2026) Table 45. Global Tubular Injection Vial Sales Market Share by Type (2027-2032) Table 46. Global Tubular Injection Vial Price by Type (2021-2026) & (USD/unit) Table 47. Global Tubular Injection Vial Price by Type (2027-2032) & (USD/unit) Table 48. Global Tubular Injection Vial Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Tubular Injection Vial Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Tubular Injection Vial Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Tubular Injection Vial Revenue Market Share by Application (2021-2026) Table 52. Global Tubular Injection Vial Revenue Market Share by Application (2027-2032) Table 53. Global Tubular Injection Vial Sales by Application 2021 VS 2025 VS 2032 (M units) Table 54. Global Tubular Injection Vial Sales by Application (2021-2026) & (M units) Table 55. Global Tubular Injection Vial Sales by Application (2027-2032) & (M units) Table 56. Global Tubular Injection Vial Sales Market Share by Application (2021-2026) Table 57. Global Tubular Injection Vial Sales Market Share by Application (2027-2032) Table 58. Global Tubular Injection Vial Price by Application (2021-2026) & (USD/unit) Table 59. Global Tubular Injection Vial Price by Application (2027-2032) & (USD/unit) Table 60. SGD Company Information Table 61. SGD Business Overview Table 62. SGD Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 63. SGD Tubular Injection Vial Product Portfolio Table 64. SGD Recent Development Table 65. SCHOTT Pharma Company Information Table 66. SCHOTT Pharma Business Overview Table 67. SCHOTT Pharma Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. SCHOTT Pharma Tubular Injection Vial Product Portfolio Table 69. SCHOTT Pharma Recent Development Table 70. Gerresheimer AG Company Information Table 71. Gerresheimer AG Business Overview Table 72. Gerresheimer AG Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Gerresheimer AG Tubular Injection Vial Product Portfolio Table 74. Gerresheimer AG Recent Development Table 75. DWK Life Sciences Company Information Table 76. DWK Life Sciences Business Overview Table 77. DWK Life Sciences Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. DWK Life Sciences Tubular Injection Vial Product Portfolio Table 79. DWK Life Sciences Recent Development Table 80. Stevanato Group Company Information Table 81. Stevanato Group Business Overview Table 82. Stevanato Group Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Stevanato Group Tubular Injection Vial Product Portfolio Table 84. Stevanato Group Recent Development Table 85. Corning Company Information Table 86. Corning Business Overview Table 87. Corning Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Corning Tubular Injection Vial Product Portfolio Table 89. Corning Recent Development Table 90. Nipro Corporation Company Information Table 91. Nipro Corporation Business Overview Table 92. Nipro Corporation Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Nipro Corporation Tubular Injection Vial Product Portfolio Table 94. Nipro Corporation Recent Development Table 95. Daikyo Seiko Company Information Table 96. Daikyo Seiko Business Overview Table 97. Daikyo Seiko Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Daikyo Seiko Tubular Injection Vial Product Portfolio Table 99. Daikyo Seiko Recent Development Table 100. West Pharmaceutical Company Information Table 101. West Pharmaceutical Business Overview Table 102. West Pharmaceutical Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. West Pharmaceutical Tubular Injection Vial Product Portfolio Table 104. West Pharmaceutical Recent Development Table 105. Radpharm Scientific Company Information Table 106. Radpharm Scientific Business Overview Table 107. Radpharm Scientific Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Radpharm Scientific Tubular Injection Vial Product Portfolio Table 109. Radpharm Scientific Recent Development Table 110. Pacific Vial Manufacturing Company Information Table 111. Pacific Vial Manufacturing Business Overview Table 112. Pacific Vial Manufacturing Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Pacific Vial Manufacturing Tubular Injection Vial Product Portfolio Table 114. Pacific Vial Manufacturing Recent Development Table 115. Ningbo Zhengli Pharmaceutical Packaging Company Information Table 116. Ningbo Zhengli Pharmaceutical Packaging Business Overview Table 117. Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 119. Ningbo Zhengli Pharmaceutical Packaging Recent Development Table 120. Linuo Pharmaceutical Packaging Company Information Table 121. Linuo Pharmaceutical Packaging Business Overview Table 122. Linuo Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Linuo Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 124. Linuo Pharmaceutical Packaging Recent Development Table 125. Chongqing Zhengchuan Pharmaceutical Packaging Company Information Table 126. Chongqing Zhengchuan Pharmaceutical Packaging Business Overview Table 127. Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 129. Chongqing Zhengchuan Pharmaceutical Packaging Recent Development Table 130. Shandong Pharmaceutical Glass Company Information Table 131. Shandong Pharmaceutical Glass Business Overview Table 132. Shandong Pharmaceutical Glass Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Shandong Pharmaceutical Glass Tubular Injection Vial Product Portfolio Table 134. Shandong Pharmaceutical Glass Recent Development Table 135. CANGZHOU FOUR STARS GLASS Company Information Table 136. CANGZHOU FOUR STARS GLASS Business Overview Table 137. CANGZHOU FOUR STARS GLASS Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. CANGZHOU FOUR STARS GLASS Tubular Injection Vial Product Portfolio Table 139. CANGZHOU FOUR STARS GLASS Recent Development Table 140. Anhui Huaxin Pharmaceutical Glass Products Company Information Table 141. Anhui Huaxin Pharmaceutical Glass Products Business Overview Table 142. Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Product Portfolio Table 144. Anhui Huaxin Pharmaceutical Glass Products Recent Development Table 145. Jiyuan Zhengyu Industrial Company Information Table 146. Jiyuan Zhengyu Industrial Business Overview Table 147. Jiyuan Zhengyu Industrial Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Jiyuan Zhengyu Industrial Tubular Injection Vial Product Portfolio Table 149. Jiyuan Zhengyu Industrial Recent Development Table 150. Taian Youlyy Industrial Company Information Table 151. Taian Youlyy Industrial Business Overview Table 152. Taian Youlyy Industrial Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Taian Youlyy Industrial Tubular Injection Vial Product Portfolio Table 154. Taian Youlyy Industrial Recent Development Table 155. Nantong Xinde Medical Packing Material Company Information Table 156. Nantong Xinde Medical Packing Material Business Overview Table 157. Nantong Xinde Medical Packing Material Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. Nantong Xinde Medical Packing Material Tubular Injection Vial Product Portfolio Table 159. Nantong Xinde Medical Packing Material Recent Development Table 160. Chengdu Jingu Medicinal Packing Company Information Table 161. Chengdu Jingu Medicinal Packing Business Overview Table 162. Chengdu Jingu Medicinal Packing Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. Chengdu Jingu Medicinal Packing Tubular Injection Vial Product Portfolio Table 164. Chengdu Jingu Medicinal Packing Recent Development Table 165. North America Tubular Injection Vial Revenue by Type (2021-2026) & (US$ Million) Table 166. North America Tubular Injection Vial Revenue by Type (2027-2032) & (US$ Million) Table 167. North America Tubular Injection Vial Sales by Type (2021-2026) & (M units) Table 168. North America Tubular Injection Vial Sales by Type (2027-2032) & (M units) Table 169. North America Tubular Injection Vial Sales Price by Type (2021-2026) & (USD/unit) Table 170. North America Tubular Injection Vial Sales Price by Type (2027-2032) & (USD/unit) Table 171. North America Tubular Injection Vial Revenue by Application (2021-2026) & (US$ Million) Table 172. North America Tubular Injection Vial Revenue by Application (2027-2032) & (US$ Million) Table 173. North America Tubular Injection Vial Sales by Application (2021-2026) & (M units) Table 174. North America Tubular Injection Vial Sales by Application (2027-2032) & (M units) Table 175. North America Tubular Injection Vial Sales Price by Application (2021-2026) & (USD/unit) Table 176. North America Tubular Injection Vial Sales Price by Application (2027-2032) & (USD/unit) Table 177. North America Tubular Injection Vial Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. North America Tubular Injection Vial Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. North America Tubular Injection Vial Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. North America Tubular Injection Vial Sales by Country (2021 VS 2025 VS 2032) & (M units) Table 181. North America Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 182. North America Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 183. North America Tubular Injection Vial Sales Price by Country (2021-2026) & (USD/unit) Table 184. North America Tubular Injection Vial Sales Price by Country (2027-2032) & (USD/unit) Table 185. United States Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 186. Canada Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 187. Mexico Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 188. Europe Tubular Injection Vial Revenue by Type (2021-2026) & (US$ Million) Table 189. Europe Tubular Injection Vial Revenue by Type (2027-2032) & (US$ Million) Table 190. Europe Tubular Injection Vial Sales by Type (2021-2026) & (M units) Table 191. Europe Tubular Injection Vial Sales by Type (2027-2032) & (M units) Table 192. Europe Tubular Injection Vial Sales Price by Type (2021-2026) & (USD/unit) Table 193. Europe Tubular Injection Vial Sales Price by Type (2027-2032) & (USD/unit) Table 194. Europe Tubular Injection Vial Revenue by Application (2021-2026) & (US$ Million) Table 195. Europe Tubular Injection Vial Revenue by Application (2027-2032) & (US$ Million) Table 196. Europe Tubular Injection Vial Sales by Application (2021-2026) & (M units) Table 197. Europe Tubular Injection Vial Sales by Application (2027-2032) & (M units) Table 198. Europe Tubular Injection Vial Sales Price by Application (2021-2026) & (USD/unit) Table 199. Europe Tubular Injection Vial Sales Price by Application (2027-2032) & (USD/unit) Table 200. Europe Tubular Injection Vial Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Europe Tubular Injection Vial Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Europe Tubular Injection Vial Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Europe Tubular Injection Vial Sales by Country (2021 VS 2025 VS 2032) & (M units) Table 204. Europe Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 205. Europe Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 206. Europe Tubular Injection Vial Sales Price by Country (2021-2026) & (USD/unit) Table 207. Europe Tubular Injection Vial Sales Price by Country (2027-2032) & (USD/unit) Table 208. Germany Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 209. France Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 210. U.K. Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 211. Italy Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 212. Russia Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 213. Spain Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 214. Netherlands Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 215. Switzerland Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 216. Sweden Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 217. Poland Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 218. China Tubular Injection Vial Revenue by Type (2021-2026) & (US$ Million) Table 219. China Tubular Injection Vial Revenue by Type (2027-2032) & (US$ Million) Table 220. China Tubular Injection Vial Sales by Type (2021-2026) & (M units) Table 221. China Tubular Injection Vial Sales by Type (2027-2032) & (M units) Table 222. China Tubular Injection Vial Sales Price by Type (2021-2026) & (USD/unit) Table 223. China Tubular Injection Vial Sales Price by Type (2027-2032) & (USD/unit) Table 224. China Tubular Injection Vial Revenue by Application (2021-2026) & (US$ Million) Table 225. China Tubular Injection Vial Revenue by Application (2027-2032) & (US$ Million) Table 226. China Tubular Injection Vial Sales by Application (2021-2026) & (M units) Table 227. China Tubular Injection Vial Sales by Application (2027-2032) & (M units) Table 228. China Tubular Injection Vial Sales Price by Application (2021-2026) & (USD/unit) Table 229. China Tubular Injection Vial Sales Price by Application (2027-2032) & (USD/unit) Table 230. Asia Tubular Injection Vial Revenue by Type (2021-2026) & (US$ Million) Table 231. Asia Tubular Injection Vial Revenue by Type (2027-2032) & (US$ Million) Table 232. Asia Tubular Injection Vial Sales by Type (2021-2026) & (M units) Table 233. Asia Tubular Injection Vial Sales by Type (2027-2032) & (M units) Table 234. Asia Tubular Injection Vial Sales Price by Type (2021-2026) & (USD/unit) Table 235. Asia Tubular Injection Vial Sales Price by Type (2027-2032) & (USD/unit) Table 236. Asia Tubular Injection Vial Revenue by Application (2021-2026) & (US$ Million) Table 237. Asia Tubular Injection Vial Revenue by Application (2027-2032) & (US$ Million) Table 238. Asia Tubular Injection Vial Sales by Application (2021-2026) & (M units) Table 239. Asia Tubular Injection Vial Sales by Application (2027-2032) & (M units) Table 240. Asia Tubular Injection Vial Sales Price by Application (2021-2026) & (USD/unit) Table 241. Asia Tubular Injection Vial Sales Price by Application (2027-2032) & (USD/unit) Table 242. Asia Tubular Injection Vial Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 243. Asia Tubular Injection Vial Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 244. Asia Tubular Injection Vial Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 245. Asia Tubular Injection Vial Sales by Country (2021 VS 2025 VS 2032) & (M units) Table 246. Asia Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 247. Asia Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 248. Asia Tubular Injection Vial Sales Price by Country (2021-2026) & (USD/unit) Table 249. Asia Tubular Injection Vial Sales Price by Country (2027-2032) & (USD/unit) Table 250. Japan Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 251. South Korea Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 252. India Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 253. Australia Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 254. Taiwan Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 255. Southeast Asia Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 256. SAMEA Tubular Injection Vial Revenue by Type (2021-2026) & (US$ Million) Table 257. SAMEA Tubular Injection Vial Revenue by Type (2027-2032) & (US$ Million) Table 258. SAMEA Tubular Injection Vial Sales by Type (2021-2026) & (M units) Table 259. SAMEA Tubular Injection Vial Sales by Type (2027-2032) & (M units) Table 260. SAMEA Tubular Injection Vial Sales Price by Type (2021-2026) & (USD/unit) Table 261. SAMEA Tubular Injection Vial Sales Price by Type (2027-2032) & (USD/unit) Table 262. SAMEA Tubular Injection Vial Revenue by Application (2021-2026) & (US$ Million) Table 263. SAMEA Tubular Injection Vial Revenue by Application (2027-2032) & (US$ Million) Table 264. SAMEA Tubular Injection Vial Sales by Application (2021-2026) & (M units) Table 265. SAMEA Tubular Injection Vial Sales by Application (2027-2032) & (M units) Table 266. SAMEA Tubular Injection Vial Sales Price by Application (2021-2026) & (USD/unit) Table 267. SAMEA Tubular Injection Vial Sales Price by Application (2027-2032) & (USD/unit) Table 268. SAMEA Tubular Injection Vial Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 269. SAMEA Tubular Injection Vial Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 270. SAMEA Tubular Injection Vial Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 271. SAMEA Tubular Injection Vial Sales by Country (2021 VS 2025 VS 2032) & (M units) Table 272. SAMEA Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 273. SAMEA Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 274. SAMEA Tubular Injection Vial Sales Price by Country (2021-2026) & (USD/unit) Table 275. SAMEA Tubular Injection Vial Sales Price by Country (2027-2032) & (USD/unit) Table 276. Brazil Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 277. Argentina Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 278. Chile Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 279. Colombia Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 280. Peru Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 281. Saudi Arabia Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 282. Israel Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 283. UAE Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 284. Turkey Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 285. Iran Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 286. Egypt Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Table 287. Key Raw Materials Table 288. Raw Materials Key Suppliers Table 289. Tubular Injection Vial Distributors List Table 290. Tubular Injection Vial Customers List Table 291. Research Programs/Design for This Report Table 292. Authors List of This Report Table 293. Secondary Sources Table 294. Primary Sources List of Figures Figure 1. Tubular Injection Vial Image Figure 2. Global Tubular Injection Vial Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tubular Injection Vial Market Size Share 2021 VS 2025 VS 2032 Figure 4. Low Borosilicate Tubular Injection Vial Image Figure 5. Medium Borosilicate Tubular Injection Vial Image Figure 6. High Borosilicate Tubular Injection Vial Image Figure 7. Soda-lime Tubular Injection Vial Image Figure 8. Global Tubular Injection Vial Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Tubular Injection Vial Market Size Share 2021 VS 2025 VS 2032 Figure 10. Biologicals Image Figure 11. Lyophilized Powder Injection Image Figure 12. Vaccines Image Figure 13. Other Image Figure 14. Global Tubular Injection Vial Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Tubular Injection Vial Revenue (2021-2032) & (US$ Million) Figure 16. Global Tubular Injection Vial Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Tubular Injection Vial Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Tubular Injection Vial Revenue Market Share by Region (2021-2032) Figure 19. Global Tubular Injection Vial Sales (2021-2032) & (M units) Figure 20. Global Tubular Injection Vial Sales by Region: 2021 VS 2025 VS 2032 (M units) Figure 21. Global Tubular Injection Vial Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Tubular Injection Vial Sales YoY (2021-2032) & (M units) Figure 23. Europe Tubular Injection Vial Sales YoY (2021-2032) & (M units) Figure 24. China Tubular Injection Vial Sales YoY (2021-2032) & (M units) Figure 25. Asia (Excluding China) Tubular Injection Vial Sales YoY (2021-2032) & (M units) Figure 26. South America, Middle East and Africa Tubular Injection Vial Sales YoY (2021-2032) & (M units) Figure 27. Global Tubular Injection Vial Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Tubular Injection Vial Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Tubular Injection Vial Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Tubular Injection Vial Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Tubular Injection Vial Revenue Market Share by Type (2021-2032) Figure 33. Global Tubular Injection Vial Sales by Type (2021 VS 2025 VS 2032) & (M units) Figure 34. Global Tubular Injection Vial Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Tubular Injection Vial Sales Market Share by Type (2021-2032) Figure 36. Global Tubular Injection Vial Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Tubular Injection Vial Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Tubular Injection Vial Revenue Market Share by Application (2021-2032) Figure 39. Global Tubular Injection Vial Sales by Application (2021 VS 2025 VS 2032) & (M units) Figure 40. Global Tubular Injection Vial Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Tubular Injection Vial Sales Market Share by Application (2021-2032) Figure 42. North America Tubular Injection Vial Revenue Share by Type (2021-2032) Figure 43. North America Tubular Injection Vial Sales Share by Type (2021-2032) Figure 44. North America Tubular Injection Vial Revenue Share by Application (2021-2032) Figure 45. North America Tubular Injection Vial Sales Share by Application (2021-2032) Figure 46. North America Tubular Injection Vial Revenue Share by Country (2021-2032) Figure 47. North America Tubular Injection Vial Sales Share by Country (2021-2032) Figure 48. Europe Tubular Injection Vial Revenue Share by Type (2021-2032) Figure 49. Europe Tubular Injection Vial Sales Share by Type (2021-2032) Figure 50. Europe Tubular Injection Vial Revenue Share by Application (2021-2032) Figure 51. Europe Tubular Injection Vial Sales Share by Application (2021-2032) Figure 52. Europe Tubular Injection Vial Revenue Share by Country (2021-2032) Figure 53. Europe Tubular Injection Vial Sales Share by Country (2021-2032) Figure 54. China Tubular Injection Vial Revenue Share by Type (2021-2032) Figure 55. China Tubular Injection Vial Sales Share by Type (2021-2032) Figure 56. China Tubular Injection Vial Revenue Share by Application (2021-2032) Figure 57. China Tubular Injection Vial Sales Share by Application (2021-2032) Figure 58. Asia Tubular Injection Vial Revenue Share by Type (2021-2032) Figure 59. Asia Tubular Injection Vial Sales Share by Type (2021-2032) Figure 60. Asia Tubular Injection Vial Revenue Share by Application (2021-2032) Figure 61. Asia Tubular Injection Vial Sales Share by Application (2021-2032) Figure 62. Asia Tubular Injection Vial Revenue Share by Country (2021-2032) Figure 63. Asia Tubular Injection Vial Sales Share by Country (2021-2032) Figure 64. SAMEA Tubular Injection Vial Revenue Share by Type (2021-2032) Figure 65. SAMEA Tubular Injection Vial Sales Share by Type (2021-2032) Figure 66. SAMEA Tubular Injection Vial Revenue Share by Application (2021-2032) Figure 67. SAMEA Tubular Injection Vial Sales Share by Application (2021-2032) Figure 68. SAMEA Tubular Injection Vial Revenue Share by Country (2021-2032) Figure 69. SAMEA Tubular Injection Vial Sales Share by Country (2021-2032) Figure 70. Tubular Injection Vial Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Tubular Injection Vial Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Low Borosilicate Tubular Injection Vial
  • Medium Borosilicate Tubular Injection Vial
  • High Borosilicate Tubular Injection Vial
  • Soda-lime Tubular Injection Vial
Applications
  • Biologicals
  • Lyophilized Powder Injection
  • Vaccines
  • Other
Companies covered
  • SGD
  • SCHOTT Pharma
  • Gerresheimer AG
  • DWK Life Sciences
  • Stevanato Group
  • Corning
  • Nipro Corporation
  • Daikyo Seiko
  • West Pharmaceutical
  • Radpharm Scientific
  • Pacific Vial Manufacturing
  • Ningbo Zhengli Pharmaceutical Packaging
  • Linuo Pharmaceutical Packaging
  • Chongqing Zhengchuan Pharmaceutical Packaging
  • Shandong Pharmaceutical Glass
  • CANGZHOU FOUR STARS GLASS
  • Anhui Huaxin Pharmaceutical Glass Products
  • Jiyuan Zhengyu Industrial
  • Taian Youlyy Industrial
  • Nantong Xinde Medical Packing Material
  • Chengdu Jingu Medicinal Packing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tubular Injection Vial Market by Type
  3. 1.2.1 Global Tubular Injection Vial Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Low Borosilicate Tubular Injection Vial
  5. 1.2.3 Medium Borosilicate Tubular Injection Vial
  6. 1.2.4 High Borosilicate Tubular Injection Vial
  7. 1.2.5 Soda-lime Tubular Injection Vial
  8. 1.3 Tubular Injection Vial Market by Application
  9. 1.3.1 Global Tubular Injection Vial Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Biologicals
  11. 1.3.3 Lyophilized Powder Injection
  12. 1.3.4 Vaccines
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Tubular Injection Vial Market Dynamics
  1. 2.1 Tubular Injection Vial Industry Trends
  2. 2.2 Tubular Injection Vial Industry Drivers
  3. 2.3 Tubular Injection Vial Industry Opportunities and Challenges
  4. 2.4 Tubular Injection Vial Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tubular Injection Vial Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tubular Injection Vial Revenue by Region
  3. 3.2.1 Global Tubular Injection Vial Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tubular Injection Vial Revenue by Region (2021-2026)
  5. 3.2.3 Global Tubular Injection Vial Revenue by Region (2027-2032)
  6. 3.2.4 Global Tubular Injection Vial Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tubular Injection Vial Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tubular Injection Vial Sales by Region
  9. 3.4.1 Global Tubular Injection Vial Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tubular Injection Vial Sales by Region (2021-2026)
  11. 3.4.3 Global Tubular Injection Vial Sales by Region (2027-2032)
  12. 3.4.4 Global Tubular Injection Vial Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tubular Injection Vial Revenue by Manufacturers
  2. 4.1.1 Global Tubular Injection Vial Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tubular Injection Vial Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tubular Injection Vial Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tubular Injection Vial Sales by Manufacturers
  6. 4.2.1 Global Tubular Injection Vial Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tubular Injection Vial Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tubular Injection Vial Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tubular Injection Vial Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tubular Injection Vial Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tubular Injection Vial Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tubular Injection Vial Manufacturers, Product Type & Application
  13. 4.7 Global Tubular Injection Vial Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tubular Injection Vial Market CR5 and HHI
  16. 4.8.2 2025 Tubular Injection Vial Tier 1, Tier 2, and Tier 3
5 Tubular Injection Vial Market by Type
  1. 5.1 Global Tubular Injection Vial Revenue by Type
  2. 5.1.1 Global Tubular Injection Vial Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tubular Injection Vial Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tubular Injection Vial Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tubular Injection Vial Sales by Type
  6. 5.2.1 Global Tubular Injection Vial Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tubular Injection Vial Sales by Type (2021-2032) & (M units)
  8. 5.2.3 Global Tubular Injection Vial Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tubular Injection Vial Price by Type
6 Tubular Injection Vial Market by Application
  1. 6.1 Global Tubular Injection Vial Revenue by Application
  2. 6.1.1 Global Tubular Injection Vial Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tubular Injection Vial Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tubular Injection Vial Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tubular Injection Vial Sales by Application
  6. 6.2.1 Global Tubular Injection Vial Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tubular Injection Vial Sales by Application (2021-2032) & (M units)
  8. 6.2.3 Global Tubular Injection Vial Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tubular Injection Vial Price by Application
7 Company Profiles
  1. 7.1 SGD
  2. 7.1.1 SGD Company Information
  3. 7.1.2 SGD Business Overview
  4. 7.1.3 SGD Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 SGD Tubular Injection Vial Product Portfolio
  6. 7.1.5 SGD Recent Developments
  7. 7.2 SCHOTT Pharma
  8. 7.2.1 SCHOTT Pharma Company Information
  9. 7.2.2 SCHOTT Pharma Business Overview
  10. 7.2.3 SCHOTT Pharma Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 SCHOTT Pharma Tubular Injection Vial Product Portfolio
  12. 7.2.5 SCHOTT Pharma Recent Developments
  13. 7.3 Gerresheimer AG
  14. 7.3.1 Gerresheimer AG Company Information
  15. 7.3.2 Gerresheimer AG Business Overview
  16. 7.3.3 Gerresheimer AG Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Gerresheimer AG Tubular Injection Vial Product Portfolio
  18. 7.3.5 Gerresheimer AG Recent Developments
  19. 7.4 DWK Life Sciences
  20. 7.4.1 DWK Life Sciences Company Information
  21. 7.4.2 DWK Life Sciences Business Overview
  22. 7.4.3 DWK Life Sciences Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 DWK Life Sciences Tubular Injection Vial Product Portfolio
  24. 7.4.5 DWK Life Sciences Recent Developments
  25. 7.5 Stevanato Group
  26. 7.5.1 Stevanato Group Company Information
  27. 7.5.2 Stevanato Group Business Overview
  28. 7.5.3 Stevanato Group Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Stevanato Group Tubular Injection Vial Product Portfolio
  30. 7.5.5 Stevanato Group Recent Developments
  31. 7.6 Corning
  32. 7.6.1 Corning Company Information
  33. 7.6.2 Corning Business Overview
  34. 7.6.3 Corning Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Corning Tubular Injection Vial Product Portfolio
  36. 7.6.5 Corning Recent Developments
  37. 7.7 Nipro Corporation
  38. 7.7.1 Nipro Corporation Company Information
  39. 7.7.2 Nipro Corporation Business Overview
  40. 7.7.3 Nipro Corporation Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nipro Corporation Tubular Injection Vial Product Portfolio
  42. 7.7.5 Nipro Corporation Recent Developments
  43. 7.8 Daikyo Seiko
  44. 7.8.1 Daikyo Seiko Company Information
  45. 7.8.2 Daikyo Seiko Business Overview
  46. 7.8.3 Daikyo Seiko Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Daikyo Seiko Tubular Injection Vial Product Portfolio
  48. 7.8.5 Daikyo Seiko Recent Developments
  49. 7.9 West Pharmaceutical
  50. 7.9.1 West Pharmaceutical Company Information
  51. 7.9.2 West Pharmaceutical Business Overview
  52. 7.9.3 West Pharmaceutical Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 West Pharmaceutical Tubular Injection Vial Product Portfolio
  54. 7.9.5 West Pharmaceutical Recent Developments
  55. 7.10 Radpharm Scientific
  56. 7.10.1 Radpharm Scientific Company Information
  57. 7.10.2 Radpharm Scientific Business Overview
  58. 7.10.3 Radpharm Scientific Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Radpharm Scientific Tubular Injection Vial Product Portfolio
  60. 7.10.5 Radpharm Scientific Recent Developments
  61. 7.11 Pacific Vial Manufacturing
  62. 7.11.1 Pacific Vial Manufacturing Company Information
  63. 7.11.2 Pacific Vial Manufacturing Business Overview
  64. 7.11.3 Pacific Vial Manufacturing Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Pacific Vial Manufacturing Tubular Injection Vial Product Portfolio
  66. 7.11.5 Pacific Vial Manufacturing Recent Developments
  67. 7.12 Ningbo Zhengli Pharmaceutical Packaging
  68. 7.12.1 Ningbo Zhengli Pharmaceutical Packaging Company Information
  69. 7.12.2 Ningbo Zhengli Pharmaceutical Packaging Business Overview
  70. 7.12.3 Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  72. 7.12.5 Ningbo Zhengli Pharmaceutical Packaging Recent Developments
  73. 7.13 Linuo Pharmaceutical Packaging
  74. 7.13.1 Linuo Pharmaceutical Packaging Company Information
  75. 7.13.2 Linuo Pharmaceutical Packaging Business Overview
  76. 7.13.3 Linuo Pharmaceutical Packaging Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Linuo Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  78. 7.13.5 Linuo Pharmaceutical Packaging Recent Developments
  79. 7.14 Chongqing Zhengchuan Pharmaceutical Packaging
  80. 7.14.1 Chongqing Zhengchuan Pharmaceutical Packaging Company Information
  81. 7.14.2 Chongqing Zhengchuan Pharmaceutical Packaging Business Overview
  82. 7.14.3 Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  84. 7.14.5 Chongqing Zhengchuan Pharmaceutical Packaging Recent Developments
  85. 7.15 Shandong Pharmaceutical Glass
  86. 7.15.1 Shandong Pharmaceutical Glass Company Information
  87. 7.15.2 Shandong Pharmaceutical Glass Business Overview
  88. 7.15.3 Shandong Pharmaceutical Glass Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Shandong Pharmaceutical Glass Tubular Injection Vial Product Portfolio
  90. 7.15.5 Shandong Pharmaceutical Glass Recent Developments
  91. 7.16 CANGZHOU FOUR STARS GLASS
  92. 7.16.1 CANGZHOU FOUR STARS GLASS Company Information
  93. 7.16.2 CANGZHOU FOUR STARS GLASS Business Overview
  94. 7.16.3 CANGZHOU FOUR STARS GLASS Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 CANGZHOU FOUR STARS GLASS Tubular Injection Vial Product Portfolio
  96. 7.16.5 CANGZHOU FOUR STARS GLASS Recent Developments
  97. 7.17 Anhui Huaxin Pharmaceutical Glass Products
  98. 7.17.1 Anhui Huaxin Pharmaceutical Glass Products Company Information
  99. 7.17.2 Anhui Huaxin Pharmaceutical Glass Products Business Overview
  100. 7.17.3 Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Product Portfolio
  102. 7.17.5 Anhui Huaxin Pharmaceutical Glass Products Recent Developments
  103. 7.18 Jiyuan Zhengyu Industrial
  104. 7.18.1 Jiyuan Zhengyu Industrial Company Information
  105. 7.18.2 Jiyuan Zhengyu Industrial Business Overview
  106. 7.18.3 Jiyuan Zhengyu Industrial Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Jiyuan Zhengyu Industrial Tubular Injection Vial Product Portfolio
  108. 7.18.5 Jiyuan Zhengyu Industrial Recent Developments
  109. 7.19 Taian Youlyy Industrial
  110. 7.19.1 Taian Youlyy Industrial Company Information
  111. 7.19.2 Taian Youlyy Industrial Business Overview
  112. 7.19.3 Taian Youlyy Industrial Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Taian Youlyy Industrial Tubular Injection Vial Product Portfolio
  114. 7.19.5 Taian Youlyy Industrial Recent Developments
  115. 7.20 Nantong Xinde Medical Packing Material
  116. 7.20.1 Nantong Xinde Medical Packing Material Company Information
  117. 7.20.2 Nantong Xinde Medical Packing Material Business Overview
  118. 7.20.3 Nantong Xinde Medical Packing Material Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Nantong Xinde Medical Packing Material Tubular Injection Vial Product Portfolio
  120. 7.20.5 Nantong Xinde Medical Packing Material Recent Developments
  121. 7.21 Chengdu Jingu Medicinal Packing
  122. 7.21.1 Chengdu Jingu Medicinal Packing Company Information
  123. 7.21.2 Chengdu Jingu Medicinal Packing Business Overview
  124. 7.21.3 Chengdu Jingu Medicinal Packing Tubular Injection Vial Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Chengdu Jingu Medicinal Packing Tubular Injection Vial Product Portfolio
  126. 7.21.5 Chengdu Jingu Medicinal Packing Recent Developments
8 North America
  1. 8.1 North America Tubular Injection Vial Market Size by Type
  2. 8.1.1 North America Tubular Injection Vial Revenue by Type (2021-2032)
  3. 8.1.2 North America Tubular Injection Vial Sales by Type (2021-2032)
  4. 8.1.3 North America Tubular Injection Vial Price by Type (2021-2032)
  5. 8.2 North America Tubular Injection Vial Market Size by Application
  6. 8.2.1 North America Tubular Injection Vial Revenue by Application (2021-2032)
  7. 8.2.2 North America Tubular Injection Vial Sales by Application (2021-2032)
  8. 8.2.3 North America Tubular Injection Vial Price by Application (2021-2032)
  9. 8.3 North America Tubular Injection Vial Market Size by Country
  10. 8.3.1 North America Tubular Injection Vial Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tubular Injection Vial Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tubular Injection Vial Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Tubular Injection Vial Market Size by Type
  2. 9.1.1 Europe Tubular Injection Vial Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tubular Injection Vial Sales by Type (2021-2032)
  4. 9.1.3 Europe Tubular Injection Vial Price by Type (2021-2032)
  5. 9.2 Europe Tubular Injection Vial Market Size by Application
  6. 9.2.1 Europe Tubular Injection Vial Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tubular Injection Vial Sales by Application (2021-2032)
  8. 9.2.3 Europe Tubular Injection Vial Price by Application (2021-2032)
  9. 9.3 Europe Tubular Injection Vial Market Size by Country
  10. 9.3.1 Europe Tubular Injection Vial Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tubular Injection Vial Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tubular Injection Vial Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Tubular Injection Vial Market Size by Type
  2. 10.1.1 China Tubular Injection Vial Revenue by Type (2021-2032)
  3. 10.1.2 China Tubular Injection Vial Sales by Type (2021-2032)
  4. 10.1.3 China Tubular Injection Vial Price by Type (2021-2032)
  5. 10.2 China Tubular Injection Vial Market Size by Application
  6. 10.2.1 China Tubular Injection Vial Revenue by Application (2021-2032)
  7. 10.2.2 China Tubular Injection Vial Sales by Application (2021-2032)
  8. 10.2.3 China Tubular Injection Vial Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tubular Injection Vial Market Size by Type
  2. 11.1.1 Asia Tubular Injection Vial Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tubular Injection Vial Sales by Type (2021-2032)
  4. 11.1.3 Asia Tubular Injection Vial Price by Type (2021-2032)
  5. 11.2 Asia Tubular Injection Vial Market Size by Application
  6. 11.2.1 Asia Tubular Injection Vial Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tubular Injection Vial Sales by Application (2021-2032)
  8. 11.2.3 Asia Tubular Injection Vial Price by Application (2021-2032)
  9. 11.3 Asia Tubular Injection Vial Market Size by Country
  10. 11.3.1 Asia Tubular Injection Vial Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tubular Injection Vial Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tubular Injection Vial Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tubular Injection Vial Market Size by Type
  2. 12.1.1 SAMEA Tubular Injection Vial Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tubular Injection Vial Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tubular Injection Vial Price by Type (2021-2032)
  5. 12.2 SAMEA Tubular Injection Vial Market Size by Application
  6. 12.2.1 SAMEA Tubular Injection Vial Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tubular Injection Vial Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tubular Injection Vial Price by Application (2021-2032)
  9. 12.3 SAMEA Tubular Injection Vial Market Size by Country
  10. 12.3.1 SAMEA Tubular Injection Vial Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tubular Injection Vial Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tubular Injection Vial Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tubular Injection Vial Value Chain Analysis
  2. 13.1.1 Tubular Injection Vial Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tubular Injection Vial Production Mode & Process
  6. 13.2 Tubular Injection Vial Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tubular Injection Vial Distributors
  9. 13.2.3 Tubular Injection Vial Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst